ETFs with Apimeds Pharmaceuticals US, Inc. (APUS) Exposure
The following ETFs maintain exposure to Apimeds Pharmaceuticals US, Inc. (APUS). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
1 ETF Hold Apimeds Pharmaceuticals US, Inc. (APUS)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in APUS |
|---|---|---|---|---|---|---|
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | <0.01% | $25.81K | 0.34% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in APUS |
|---|---|---|---|---|---|---|
| VXF | <0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $25.81K | 0.34% |
Popular ETF Comparisons
APUS ETF Exposure FAQ
What ETFs hold Apimeds Pharmaceuticals US, Inc. stock?
Apimeds Pharmaceuticals US, Inc. (APUS) is currently held by 1 ETF in TipRanks’ ETF exposure database. The ETF(s) with exposure to APUS include Vanguard (VXF).
Which ETF has the largest exposure to APUS?
The ETF with the largest exposure to APUS is Vanguard (VXF), with approximately $25.81K in market value exposure.
How much APUS stock is held by ETFs?
ETFs currently hold approximately $25.81K worth of Apimeds Pharmaceuticals US, Inc. (APUS) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.